Ketamine concentrations in breast milk drop rapidly over the first 12 hours after a dose, following a decline pattern similar to what happens in the bloodstream. Both ketamine and its active breakdown product, norketamine, appear in milk at very low levels, and the amount an infant would actually absorb through feeding is lower still because ketamine has poor oral bioavailability. That combination of factors puts the overall risk to a breastfed infant in the low category, though the timing of when you resume nursing still matters.
How Quickly Ketamine Clears From Breast Milk
The most direct data on this comes from a study published in the Journal of Psychoactive Drugs, which collected breast milk samples from lactating women at baseline and then at 3, 6, 9, and 12 hours after injection. Ketamine levels dropped quickly across those time points, closely mirroring the drug’s known elimination pattern in blood plasma. The researchers chose 3-hour sampling intervals specifically because they exceeded ketamine’s maximum half-life in the bloodstream, which is roughly 2 to 3 hours.
Norketamine, the primary active metabolite the body produces as it processes ketamine, cleared a bit more slowly than the parent drug. This is consistent with what happens in the blood as well, where norketamine lingers slightly longer. The study noted that ketamine and norketamine do not appear to concentrate in breast milk above plasma levels, meaning the milk compartment stays in rough equilibrium with the blood rather than acting as a reservoir that traps the drug.
By 12 hours after a single dose, both ketamine and norketamine levels had declined substantially from their peaks. Most of the drop happens in the first 6 hours, with the remaining hours showing continued but smaller decreases.
Why Infant Exposure Is Considered Low
Two factors work together to limit how much ketamine a nursing infant would actually take in. First, the concentrations that make it into breast milk are already very low. Second, ketamine has poor oral bioavailability, meaning that even if an infant swallows milk containing trace amounts, their gut absorbs only a small fraction of it. In adults, oral bioavailability for ketamine is estimated at around 16 to 24 percent. For an infant consuming small volumes of milk with already-low drug levels, the effective dose reaching the bloodstream would be a tiny fraction of the mother’s dose.
The LactMed database, maintained by the National Institutes of Health as a reference for drugs and lactation, summarizes ketamine’s profile as posing “a low risk to breastfed infants” based on these pharmacokinetic characteristics. No published data currently document measurable ketamine levels in the blood of breastfed infants whose mothers received the drug.
Practical Timing for Nursing
No single authoritative guideline specifies an exact number of hours to wait before breastfeeding after ketamine. However, the pharmacokinetic data offer a reasonable framework. Since ketamine’s half-life is roughly 2 to 3 hours, waiting 12 hours allows for four to six half-lives to pass, which means the vast majority of the drug and its metabolites will have cleared from both blood and milk. Many clinicians use this 12-hour window as a practical benchmark.
If you need to maintain your milk supply during that waiting period, pumping and discarding is a straightforward option. Some women pump at their usual feeding intervals and discard the milk collected during the first 12 hours, then resume direct breastfeeding afterward. Having a stored supply of expressed milk set aside before a planned procedure or treatment session can make this easier to manage.
The route of administration can affect how much ketamine enters your system and how quickly it clears. Intravenous and intramuscular injections deliver the full dose directly into the bloodstream, producing higher peak levels than intranasal or oral routes. Esketamine, the nasal spray form used for treatment-resistant depression, delivers a lower total dose per session than many IV protocols, but the same general clearance timeline applies.
What to Watch For in Your Baby
If you breastfeed within the window when ketamine might still be present in milk, the signs to monitor are related to the drug’s sedative properties. Unusual sleepiness, difficulty staying awake during feeds, weak sucking, poor feeding, and slow weight gain are the key things to look for. These would indicate that the infant is being affected by residual drug exposure. In practice, given the very low milk levels and poor oral absorption, clinically meaningful effects in infants have not been reported in the medical literature, but awareness of these signs is still reasonable.
Younger infants, particularly newborns and preterm babies, metabolize drugs more slowly than older infants. If your baby is under two months old or was born prematurely, the margin for caution is narrower, and a longer waiting period before nursing may be worth considering.
Single Dose vs. Repeated Use
The clearance data described above apply to single-dose scenarios, such as ketamine used for a surgical procedure or a one-time infusion for depression. If you’re receiving ketamine on a recurring schedule, such as weekly or biweekly IV infusions for mood disorders or chronic pain, the situation is slightly different. Repeated dosing doesn’t cause ketamine to accumulate significantly in breast milk between sessions because the drug clears too quickly for that. But each session restarts the clock, so you’d want to apply the same waiting period after every treatment.
For ongoing ketamine therapy, planning nursing and pumping schedules around treatment days becomes a routine consideration. Timing your infusion right after a feeding session, then pumping and discarding for the next 12 hours, is the approach many women use to balance treatment with breastfeeding.